Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terence A Partridge

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Cell Death Discovery|July 4, 2023
Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMDDavi A G Mázala, Ravi Hindupur, Young Jae Moon, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Altered muscle niche contributes to myogenic deficit in the D2- <i>mdx</i> model of severe DMDDavi A G Mázala, Ravi Hindupur, Young Jae Moon, et al.
Human Gene Therapy|September 16, 2008
Adenovirus-based targeting in myoblasts is hampered by nonhomologous vector integrationOlga Isman, Michael L Roberts, Jennifer E Morgan, et al.
The Journal of Cell Biology|October 15, 2014
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophySherry Dadgar, Zuyi Wang, Helen Johnston, et al.
Muscle & Nerve|March 5, 2009
Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measuresChristopher F Spurney, Heather Gordish-Dressman, Alfredo D Guerron, et al.
Nature Communications|March 25, 2018
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Nature Communications|October 18, 2017
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Nature Communications|January 17, 2018
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Cell Reports|September 1, 2015
TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular DystrophyAlyson A Fiorillo, Christopher R Heier, James S Novak, et al.
Aging Cell|June 5, 2021
Human muscle stem cells are refractory to agingJames S Novak, Davi A G Mázala, Marie Nearing, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Cell Death Discovery|July 4, 2023
Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMDDavi A G Mázala, Ravi Hindupur, Young Jae Moon, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Altered muscle niche contributes to myogenic deficit in the D2- <i>mdx</i> model of severe DMDDavi A G Mázala, Ravi Hindupur, Young Jae Moon, et al.
Human Gene Therapy|September 16, 2008
Adenovirus-based targeting in myoblasts is hampered by nonhomologous vector integrationOlga Isman, Michael L Roberts, Jennifer E Morgan, et al.
The Journal of Cell Biology|October 15, 2014
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophySherry Dadgar, Zuyi Wang, Helen Johnston, et al.
Muscle & Nerve|March 5, 2009
Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measuresChristopher F Spurney, Heather Gordish-Dressman, Alfredo D Guerron, et al.
Nature Communications|March 25, 2018
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Nature Communications|October 18, 2017
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Nature Communications|January 17, 2018
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Cell Reports|September 1, 2015
TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular DystrophyAlyson A Fiorillo, Christopher R Heier, James S Novak, et al.
Aging Cell|June 5, 2021
Human muscle stem cells are refractory to agingJames S Novak, Davi A G Mázala, Marie Nearing, et al.
Pageof 7